DR ANTHONY MELVIN CRASTO,WorldDrugTracker, helping millions, A 90 % paralysed man in action for you, I am suffering from transverse mylitis and bound to a wheel chair, With death on the horizon, nothing will not stop me except God................DR ANTHONY MELVIN CRASTO Ph.D ( ICT, Mumbai) , INDIA 25Yrs Exp. in the feld of Organic Chemistry,Working for GLENMARK GENERICS at Navi Mumbai, INDIA. Serving chemists around the world. Helping them with websites on Chemistry.Million hits on google, world acclamation from industry, academia, drug authorities for websites, blogs and educational contribution
Showing posts with label 4-oxadiazol-2-yl]sulfanyl}-N-(pyrazin- 2-yl) acetamide. Show all posts
Showing posts with label 4-oxadiazol-2-yl]sulfanyl}-N-(pyrazin- 2-yl) acetamide. Show all posts

Thursday, 1 January 2015

Synthesis of 2-{[5-(diphenylmethyl)-1,3,4-oxadiazol-2-yl]sulfanyl}-N-(pyrazin- 2-yl) acetamide





2-{[5-(diphenylmethyl)-1,3,4-oxadiazol-2-yl]sulfanyl}-N-(pyrazin- 2-yl) acetamide

Molbank 20132013(2), M800; doi:10.3390/M800
Short Note

2-{[5-(Diphenylmethyl)-1,3,4-oxadiazol-2-yl]sulfanyl}-N-(pyrazin-2-yl)acetamide



1 Department of Studies in Chemistry, Mangalore University, Mangalagangotri-574 199, Karnataka, India2 Research Department of Chemistry, P. A. College of Engineering, Nadupadavu, Mangalore 574153, Karnataka, India
nbadiadka@yahoo.co.uk.

http://www.mdpi.com/1422-8599/2013/2/M800
file:///C:/Users/Inspiron/Downloads/molbank-2013-M800.pdf

S-Alkylation of 5-(diphenylmethyl)-1,3,4-oxadiazole-2(3H)-thione (3) by 2-chloro-N-(pyrazin-2-yl)acetamide (2) affords the title compound, 2-{[5-(diphenylmethyl)-1,3,4-oxadiazol-2-yl]sulfanyl}-N-(pyrazin-2-yl)acetamide (4). The intermediate (2), in turn, was prepared by the acetylation of 2-aminopyrazine (1) with chloroacetyl chloride. The structure of the newly synthesized compound is characterized by IR, NMR and mass spectral data.

Melting point: 210–212 °C.
LCMS: m/z = 404.5 (M++1).

IR (KBr): νmax (cm−1), 3201 (N-H), 3041 (Ar-H), 1699 (alkyl-CO-NH) , 1555 (C=N, Ar C=C).
1H-NMR (400 MHz, DMSO-d6): δ ppm, 4.53 (s, 2H, S-CH2), 5.93 (s, 1H, Ph2-CH), 7.22–7.36 (m,
11H, Ar-H), 8.38–8.41 (m, 2H, Ar-H), 11.15 (s, 1H, NH).


13C-NMR (100 MHz, DMSO-d6,): δ ppm, 168.52 (C=O), 166.41, 163.89 (oxadiazole C’s), 148.75,
143.11, 140.54, 139.07, 136.55, 129.14, 128.75, 127.82 (aromatic C’s), 47.61(S-CH2), 36.78 (Ph2-CH).


Elemental analysis: Calculated for C21H17N5O2S, C, 62.52%; H, 4.25%; N, 17.36%; Found: C,
62.49%; H, 4.28%; N, 17.32%.

The formation of 2-{[5-(diphenylmethyl)-1,3,4-oxadiazol-2-yl]sulfanyl}-N-(pyrazin-2-yl)acetamide
(4) was confirmed by its NMR and mass spectral data. A singlet integrating for two protons at δ 4.53
in the 1H-NMR spectrum of compound (4) was due to -S-CH2 linkage. Another singlet observed at δ
5.93 ppm was due to the proton attached the carbon for which two phenyl groups were substituted. The signals of aromatic protons merged in the regions δ 7.22–7.36 ppm and 8.38–8.41 ppm as multiplets.NH proton appeared as a singlet at δ 11.15 ppm as a singlet. Mass spectrum showed a molecular ionpeak at m/z 404.5 (M++1) corresponding to the molecular formula of C21H17N5O2S. Elemental analysis and 13C-NMR spectrum also gave satisfactory results for the title compound.






mangalore










st aloysius college mangalore


 





cock